Silverlake Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,654
Closed -$292K 398
2026
Q1
$292K Sell
4,654
-668
-13% -$53.4K 0.06% 291
2025
Q4
$507K Hold
5,322
0.11% 197
2025
Q3
$520K Sell
5,322
-88
-2% -$9.11K 0.13% 179
2025
Q2
$581K Sell
5,410
-8
-0.1% -$809 0.17% 145
2025
Q1
$547K Sell
5,418
-234
-4% -$23.6K 0.21% 123
2024
Q4
$505K Sell
5,652
-38
-0.7% -$3.35K 0.19% 130
2024
Q3
$477K Hold
5,690
0.18% 140
2024
Q2
$438K Sell
5,690
-402
-7% -$29.4K 0.18% 140
2024
Q1
$417K Sell
6,092
-6
-0.1% -$386 0.21% 128
2023
Q4
$353K Sell
6,098
-33
-0.5% -$1.76K 0.19% 138
2023
Q3
$324K Sell
6,131
-649
-10% -$34K 0.18% 150
2023
Q2
$367K Sell
6,780
-18
-0.3% -$940 0.2% 131
2023
Q1
$340K Buy
6,798
+32
+0.5% +$1.51K 0.21% 132
2022
Q4
$313K Hold
6,766
0.2% 133
2022
Q3
$262K Sell
6,766
-215
-3% -$8.63K 0.18% 143
2022
Q2
$260K Hold
6,981
0.17% 154
2022
Q1
$309K Sell
6,981
-415
-6% -$18K 0.18% 151
2021
Q4
$314K Buy
+7,396
New +$311K 0.17% 146

Other funds holding BSX

Silverlake Wealth Management's BSX Position: Q2 2026 in Review

Silverlake Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,654 shares — an estimated $292K sold.

Silverlake Wealth Management first reported a position in BSX in Q4 2021 and held it in 18 quarters. The position peaked at $581K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Silverlake Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Silverlake Wealth Management sold 4,654 Boston Scientific shares in Q2 2026, an estimated $292K.
  • Silverlake Wealth Management first reported a position in Boston Scientific in Q4 2021 and held it in 18 quarters.
  • Silverlake Wealth Management's Boston Scientific position peaked at $581K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.